1. National Center for Disaster and Trauma. 2020. Psychological support guideline for novel corona virus. Ministry of Health and Welfare.
2. World Health Organization. 2021. COVID-19 weekly epidemiological update, edition 68. 30. November. 2021.
https://apps.who.int/iris/handle/10665/350006
3. Han RH, Schmidt MN, Waits WM, Bell AK, Miller TL. 2020; Planning for mental health needs during COVID-19. Curr Psychiatry Rep. 22:12. 1–10.
https://doi.org/10.1007/s11920-020-01189-6
4. Robillard R, Saad M, Edwards J, Solomonova E, Pennestri MH, Daros A, Veissière SPL, Quilty L, Dion K, Nixon A, Phillips J, Bhatla R, Spilg E, Godbout R, Yazji B, Rushton C, Gifford WA, Gautam M, Boafo A, Swartz R, Kendzerska T. 2020; Social, financial and psychological stress during an emerging pandemic: observations from a population survey in the acute phase of COVID-19. BMJ open. 10:12. e043805
http://dx.doi.org/10.1136/bmjopen-2020-043805
5. Galbraith N, Boyda D, McFeeters D, Hassan T. 2021; The mental health of doctors during the COVID-19 pandemic. BJPsych bulletin. 45:2. 93–97.
https://doi.org/10.1192/bjb.2020.44
6. Kathirvel N. 2020; Post COVID-19 pandemic mental health challenges. Asian J Psychiatr. 53:102430
https://doi.org/10.1016/j.ajp.2020.102430
7. Wang J, Mann F, Lloyd-Evans B, Ma R, Johnson S. 2018; Associations between loneliness and perceived social support and outcomes of mental health problems: a systematic review. BMC psychiatry. 18:1. 1–16.
https://doi.org/10.1186/s12888-018-1736-5
8. Ernst M, Niederer D, Werner AM, Czaja SJ, Mikton C, Ong AD, Rosen T, Brähler E, Beutel ME. 2022; Loneliness before and during the COVID-19 pandemic: A systematic review with meta-analysis. American Psychologist.
https://doi.org/10.1037/amp0001005
9. Molteni F, Ladini R, Biolcati F, Chiesi AM, Dotti Sani GM, Guglielmi S, Maraffi M, Pedrazzani A, Segatti P, Vezzoni C. 2021; Searching for comfort in religion: insecurity and religious behaviour during the COVID-19 pandemic in Italy. European Societies. 23:sup1. S704–S720.
https://doi.org/10.1080/14616696.2020.1836383
10. Saltzman LY, Hansel TC, Bordnick PS. 2020; Loneliness, isolation, and social support factors in post-COVID-19 mental health. Psychol Trauma. 12:S1. S55–S57.
https://doi.org/10.1037/tra0000703
11. Division of Mental Health Management, Ministry of Health and Welfare. 2021. Q2 2021 “COVID19 National Mental Health Survey” Results Report. Ministry of Health and Welfare.
12. National Medical Center. 2021. 2021 “COVID-19 Public Awareness Survey” Results Report. National Medical Center.
13. Andrade G, Simões do Couto F, Câmara-Pestana L. 2020; Recommendations about the use of psychotropic medications during the COVID-19 pandemic. Acta Med Port. 33:10. 693–702.
https://doi.org/10.20344/amp.13976
14. Danta CC. 2020; Calcium channel blockers: a possible potential therapeutic strategy for the treatment of Alzheimer’s dementia patients with SARS-CoV-2 infection. ACS Chem Neurosci. 11:15. 2145–2148.
https://doi.org/10.1021/acschemneuro.0c00391
15. Sabe M, Dorsaz O, Huguelet P, Kaiser S. 2021; Toxicity of psychotropic drugs in patients with COVID-19: a systematic review. Gen Hosp Psychiatry. 70:1–9.
https://doi.org/10.1016/j.genhosppsych.2021.02.006
16. Bilbul M, Paparone P, Kim AM, Mutalik S, Ernst CL. 2020; Psychopharmacology of COVID-19. Psychosomatics. 61:5. 411–427.
https://doi.org/10.1016/j.psym.2020.05.006
17. Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. 2020; Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 7:7. 611–627.
https://doi.org/10.1016/S2215-0366(20)30203-0
18. Werner EA, Aloisio CE, Butler AD, D’Antonio KM, Kenny JM, Mitchell A, Ona S, Monk C. 2020; Addressing mental health in patients and providers during the COVID-19 pandemic. Semin Perinatol. 44:7. 151279
https://doi.org/10.1016/j.semperi.2020.151279
19. Jang S, Kim D, Yi E, Choi G, Song M, Lee E-K. 2021; Telemedicine and the use of Korean medicine for patients with COVID-19 in South Korea: observational study. JMIR Public Health Surveill. 7:1. e20236
https://doi.org/10.2196/20236
20. Kim D-S, Chu H, Min BK, Moon Y, Park S, Kim K, Park S-H, Kim Y-D, Song M, Choi G-H, Lee E. 2020; Telemedicine center of Korean medicine for treating patients with COVID-19: a retrospective analysis. Integr Med Res. 9:3. 100492
https://doi.org/10.1016/j.imr.2020.100492
21. Kwon C-Y, Kwak H-Y, Kim JW. 2020; Using mind–body modalities via telemedicine during the COVID-19 crisis: cases in the Republic of Korea. Int J Environ Res Public Health. 17:12. 4477
https://doi.org/10.3390/ijerph17124477
22. Jain FA, Walsh RN, Eisendrath SJ, Christensen S, Cahn BR. 2015; Critical analysis of the efficacy of meditation therapies for acute and subacute phase treatment of depressive disorders: a systematic review. Psychosomatics. 56:2. 140–152.
https://doi.org/10.1016/j.psym.2014.10.007
23. McCartney M, Nevitt S, Lloyd A, Hill R, White R, Duarte R. 2021; Mindfulness-based cognitive therapy for prevention and time to depressive relapse: Systematic review and network meta-analysis. Acta Psychiatrica Scandinavica. 143:1. 6–21.
https://doi.org/10.1111/acps.13242
24. V⊘llestad J, Nielsen MB, Nielsen GH. 2012; Mindfulness-and acceptance-based interventions for anxiety disorders: A systematic review and meta-analysis. British journal of clinical psychology. 51:3. 239–260.
https://doi.org/10.1111/j.2044-8260.2011.02024.x
25. Zhou X, Guo J, Lu G, Chen C, Xie Z, Liu J, Zhang C. 2020; Effects of mindfulness-based stress reduction on anxiety symptoms in young people: A systematic review and meta-analysis. Psychiatry Research. 289:113002
https://doi.org/10.1016/j.psychres.2020.113002
26. Hilton L, Maher AR, Colaiaco B, Apaydin E, Sorbero ME, Booth M, Marika S, Roberta M, Hempel S. 2017; Meditation for posttraumatic stress: Systematic review and meta-analysis. Psychological Trauma: Theory, Research, Practice, and Policy. 9:4. 453
https://doi.org/10.1037/tra0000180
27. Goyal M, Singh S, Sibinga EMS, Gould NF, Rowland-Seymour A, Sharma R, Berger Z, Sleicher D, Maron DD, Shihab HM, Ranasinghe PD, Linn S, Saha S, Bass EB, Haythornthwaite JA. 2014; Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA internal medicine. 174:3. 357–368. 10.1001/jamainternmed.2013.13018
28. Sharma M, Rush SE. 2014; Mindfulness-based stress reduction as a stress management intervention for healthy individuals: a systematic review. Journal of evidence-based complementary & alternative medicine. 19:4. 271–286.
https://doi.org/10.1177/2156587214543143
29. Pascoe MC, Thompson DR, Jenkins ZM, Ski CF. 2017; Mindfulness mediates the physiological markers of stress: Systematic review and meta-analysis. Journal of psychiatric research. 95:156–178.
https://doi.org/10.1016/j.jpsychires.2017.08.004
30. Rusch HL, Rosario M, Levison LM, Olivera A, Livingston WS, Wu T, Gill JM. 2019; The effect of mindfulness meditation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. Annals of the New York Academy of Sciences. 1445:1. 5–16.
https://doi.org/10.1111/nyas.13996
31. EBM-based Guidelines Development Committee for Korean Medicine Clinical Practice Guideline for Depression (Korea Institute of Oriental Medicine and Society of Korean Medicine Neuropsychiatry). 2016. Korean Medicine Clinical Practice Guideline for Depression. Deajeon, Korea: Elsevier Korea.
32. The Society of Korean Medicine Neuropsychiatry. 2021. Clinical practice guideline of Korean medicine for anxiety disorders. Guideline Center for Korean Medicine (G-KoM), National Development Institute of Korean Medicine.
33. The Society of Korean Medicine Neuropsychiatry. 2021. Clinical practice guideline of Korean medicine for insomnia disorder. Guideline Center for Korean Medicine (G-KoM), National Development Institute of Korean Medicine.
34. The Society of Korean Medicine Neuropsychiatry. Clinical practice guideline of Korean medicine for Hwabyung. 2021: Guideline Center for Korean Medicine (G-KoM), National Development Institute of Korean Medicine.
35. Kwon CY, Seo J, Kim SH. 2022; Development of a Manual for Disaster Medical Support Using Korean Medicine for Disaster Survivors. Journal of integrative and complementary medicine.
https://doi.org/10.1089/jicm.2022.0561
36. Behan C. 2020; The benefits of meditation and mindfulness practices during times of crisis such as COVID-19. Irish journal of psychological medicine. 37:4. 256–258.
https://doi.org/10.1017/ipm.2020.38
37. Jiménez Ó, Sánchez-Sánchez LC, García-Montes JM. 2020; Psychological impact of COVID-19 confinement and its relationship with meditation. International Journal of Environmental Research and Public Health. 17:18. 6642
https://doi.org/10.3390/ijerph17186642
38. Rasania SK. 2021; A cross--sectional study of mental wellbeing with practice of yoga and meditation during COVID-19 pandemic. Journal of Family Medicine and Primary Care. 10:4. 157610.4103/jfmpc.jfmpc_2367_20
39. Hossain MM, Tasnim S, Sultana A, Faizah F, Mazumder H, Zou L, McKyer ELJ, Ahmed HU, Ma P. 2020; Epidemiology of mental health problems in COVID-19: a review. F1000Res. 9:636
https://doi.org/10.12688/f1000research.24457.1
40. Chevance A, Gourion D, Hoertel N, Llorca PM, Thomas P, Bocher R, Moro MR, Laprévote V, Benyamina A, Fossati P, Masson M, Leaune E, Leboyer M, Gaillard R. 2020; Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review. Encephale. 46:3. 193–201.
https://doi.org/10.1016/j.encep.2020.04.005
41. Silva AFD, Estrela FM, Soares CFS, Magalhães JRFD, Lima NS, Morais AC, Gomes NP, Lima VLDA. 2020; Marital violence precipitating/intensifying elements during the Covid-19 pandemic. Cien Saude Colet. 25:9. 3475–3480.
https://doi.org/10.1590/1413-81232020259.16132020
42. Gilan D, Röthke N, Blessin M, Kunzler A, Stoffers-Winterling J, Müssig M, Yuen KSL, Tüscher O, Thrul J, Kreuter F, Sprengholz P, Betsch C, Stieglitz RD, Lieb K. 2020; Psychomorbidity, resilience, and exacerbating and protective factors during the SARS-CoV-2 pandemic. Dtsch Arztebl Int. 117:38. 625–630.
https://doi.org/10.3238/arztebl.2020.0625
43. Kunzler AM, Röthke N, Günthner L, Stoffers-Winterling J, Tüscher O, Coenen M, Rehfuess E, Schwarzer G, Binder H, Schmucker C, Meerpohl JJ, Lieb K. 2021; Mental burden and its risk and protective factors during the early phase of the SARS-CoV-2 pandemic: systematic review and meta-analyses. Global Health. 17:1. 34
https://doi.org/10.1186/s12992-021-00670-y
44. Taylor S. 2021; COVID stress syndrome: clinical and nosological considerations. Curr Psychiatry Rep. 23:4. 19
https://doi.org/10.1007/s11920-021-01226-y
45. Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Phan L, Chen-Li D, Iacobucci M, Ho R, Majeed A, McIntyre RS. 2020; Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord. 277:55–64.
https://doi.org/10.1016/j.jad.2020.08.001
46. Heiat M, Heiat F, Halaji M, Ranjbar R, Tavangar Marvasti Z, Yaali-Jahromi E, Azizi MM, Morteza Hosseini S, Badri T. 2021; Phobia and fear of COVID-19: origins, complications and management, a narrative review. Ann Ig. 33:4. 360–370.
https://doi.org/10.7416/ai.2021.2446
47. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. 2020; The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 395:10227. 912–920.
https://doi.org/10.1016/S0140-6736(20)30460-8
48. Chaimowitz GA, Upfold C, Géa LP, Qureshi A, Moulden HM, Mamak M, Bradford JMW. 2021; Stigmatization of psychiatric and justice-involved populations during the COVID-19 pandemic. Prog Neuropsychopharmacol Biol Psychiatry. 106:110150
https://doi.org/10.1016/j.pnpbp.2020.110150
49. de Figueiredo CS, Sandre PC, Portugal LCL, Mázala-de-Oliveira T, da Silva Chagas L, Raony Í, Ferreira ES, Giestal-de-Araujo E, Dos Santos AA, Bomfim PO. 2021; COVID-19 pandemic impact on children and adolescents’ mental health: biological, environmental, and social factors. Prog Neuropsychopharmacol Biol Psychiatry. 106:110171
https://doi.org/10.1016/j.pnpbp.2020.110171
50. Kotlar B, Gerson E, Petrillo S, Langer A, Tiemeier H. 2021; The impact of the COVID-19 pandemic on maternal and perinatal health: a scoping review. Reprod Health. 18:1. 10
https://doi.org/10.1186/s12978-021-01070-6
51. Grolli RE, Mingoti MED, Bertollo AG, Luzardo AR, Quevedo J, Réus GZ, Ignácio ZM. 2021; Impact of COVID-19 in the mental health in elderly: psychological and biological updates. Mol Neurobiol. 58:5. 1905–1916.
https://doi.org/10.1007/s12035-020-02249-x
52. Mosolov SN. 2020; Problems of mental health in the situation of COVID-19 pandemic. Zh Nevrol Psikhiatr Im S S Korsakova. 120:5. 7–15.
https://doi.org/10.17116/jnevro20201200517
53. Vanessa CF, Iarocci G. 2020; Child and family outcomes following pandemics: a systematic review and recommendations on COVID-19 policies. J Pediatr Psychol. 45:10. 1124–1143.
https://doi.org/10.1093/jpepsy/jsaa092
54. Cabrera MA, Karamsetty L, Simpson SA. 2020; Coronavirus and its implications for psychiatry: a rapid review of the early literature. Psychosomatics. 61:6. 607–615.
https://doi.org/10.1016/j.psym.2020.05.018
55. Mazhar K, Hussain S, Ullah R, Raza H, Aamir A, Asif A, Memon FS, Haider J, Anas M. 2020; Mental health crisis in pregnant women during current COVID-19 pandemic. Psychiatr Danub. 32:3–4. 598–599.
56. Cosco TD, Fortuna K, Wister A, Riadi I, Wagner K, Sixsmith A. 2021; COVID-19, social isolation, and mental health among older adults: a digital catch-22. J Med Internet Res. 23:5. e21864
https://doi.org/10.2196/21864
57. da Silva FCT, Neto MLR. 2021; Psychiatric symptomatology associated with depression, anxiety, distress, and insomnia in health professionals working in patients affected by COVID-19: a systematic review with meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 104:110057
https://doi.org/10.1016/j.pnpbp.2020.110057
58. da Silva FCT, Neto MLR. 2021; Psychological effects caused by the COVID-19 pandemic in health professionals: a systematic review with meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 104:110062
https://doi.org/10.1016/j.pnpbp.2020.110062
59. Varghese A, George G, Kondaguli SV, Naser AY, Khakha DC, Chatterji R. 2021; Decline in the mental health of nurses across the globe during COVID-19: a systematic review and meta-analysis. J Glob Health. 11:05009
https://doi.org/10.7189/jogh.11.05009
60. d’Ettorre G, Ceccarelli G, Santinelli L, Vassalini P, Innocenti GP, Alessandri F, Koukopoulos AE, Russo A, d’Ettorre G, Tarsitani L. 2021; Post-traumatic stress symptoms in healthcare workers dealing with the COVID-19 pandemic: a systematic review. Int J Environ Res Public Health. 18:2. 601
https://doi.org/10.3390/ijerph18020601
61. Júnior JG, Moreira MM, Pinheiro WR, de Amorim LM, Lima CKT, da Silva CGL, Neto MLR. 2020; The mental health of those whose rights have been taken away: an essay on the mental health of indigenous peoples in the face of the 2019 coronavirus (2019-nCoV) outbreak. Psychiatry Res. 289:113094
https://doi.org/10.1016/j.psychres.2020.113094
62. Furlong Y, Finnie T. 2020; Culture counts: the diverse effects of culture and society on mental health amidst COVID-19 outbreak in Australia. Ir J Psychol Med. 37:3. 237–242.
https://doi.org/10.1017/ipm.2020.37
63. Rothman S, Gunturu S, Korenis P. The mental health impact of the COVID-19 epidemic on immigrants and racial and ethnic minorities. QJM. 113:11. 779–782.
https://doi.org/10.1093/qjmed/hcaa203
64. Mukherjee S. 2020; Disparities, desperation, and divisiveness: coping with COVID-19 in India. Psychol Trauma. 12:6. 582–584.
https://doi.org/10.1037/tra0000682
65. Almeida M, Shrestha AD, Stojanac D, Miller LJ. 2020; The impact of the COVID-19 pandemic on women’s mental health. Arch Womens Ment Health. 23:6. 741–748.
https://doi.org/10.1007/s00737-020-01092-2
66. Esterwood E, Saeed SA. 2020; Past epidemics, natural disasters, COVID19, and mental health: learning from history as we deal with the present and prepare for the future. Psychiatr Q. 91:4. 1121–1133.
https://doi.org/10.1007/s11126-020-09808-4
67. Mengin A, Allé MC, Rolling J, Ligier F, Schroder C, Lalanne L, Berna F, Jardri R, Vaiva G, Geoffroy PA, Brunault P, Thibaut F, Chevance A, Giersch A. 2020; Psychopathological consequences of confinement. Encephale. 46:3S. S43–S52.
https://doi.org/10.1016/j.encep.2020.04.007
68. Chew QH, Wei KC, Vasoo S, Chua HC, Sim K. 2020; Narrative synthesis of psychological and coping responses towards emerging infectious disease outbreaks in the general population: practical considerations for the COVID-19 pandemic. Singapore Med J. 61:7. 350–356.
https://doi.org/10.11622/smedj.2020046
69. Henssler J, Stock F, van Bohemen J, Walter H, Heinz A, Brandt L. 2021; Mental health effects of infection containment strategies: quarantine and isolation-a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 271:2. 223–234.
https://doi.org/10.1007/s00406-020-01196-x
70. Blum K, Cadet JL, Baron D, Badgaiyan RD, Brewer R, Modestino EJ, Gold MS. 2020; Putative COVID-19 induction of reward deficiency syndrome (RDS) and associated behavioral addictions with potential concomitant dopamine depletion: is COVID-19 social distancing a double edged sword? Subst Use Misuse. 55:14. 2438–2442.
https://doi.org/10.1080/10826084.2020.1817086
71. Sher L. 2020; The impact of the COVID-19 pandemic on suicide rates. QJM. 113:10. 707–712.
https://doi.org/10.1093/qjmed/hcaa202
72. Fatke B, Hölzle P, Frank A, Förstl H. 2020; COVID-19 crisis: early observations on a pandemic’s psychiatric problems. Dtsch Med Wochenschr. 145:10. 675–681.
https://doi.org/10.1055/a-1147-2889
73. Anjum S, Ullah R, Rana MS, Khan HA, Memon FS, Ahmed Y, Jabeen S, Faryal R. 2020; COVID-19 pandemic: a serious threat for public mental health globally. Psychiatr Danub. 32:2. 245–250.
https://doi.org/10.24869/psyd.2020.245
74. Mallet J, Dubertret C, Le Strat Y. 2021; Addictions in the COVID-19 era: current evidence, future perspectives a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 106:110070
https://doi.org/10.1016/j.pnpbp.2020.110070
75. Bailey KL, Samuelson DR, Wyatt TA. 2021; Alcohol use disorder: a pre-existing condition for COVID-19? Alcohol. 90:11–17.
https://doi.org/10.1016/j.alcohol.2020.10.003
76. He Y, Yu R, Ren J. 2021; The correlation between psychiatric disorders and COVID-19: a narrative review. Psychiatr Danub. 33:1. 76–85.
https://doi.org/10.24869/psyd.2021.76
77. Preti E, Di Pierro R, Fanti E, Madeddu F, Calati R. 2020; Personality disorders in time of pandemic. Curr Psychiatry Rep. 22:12. 80
https://doi.org/10.1007/s11920-020-01204-w
78. Sulaimani MF, Bagadood NH. Implication of coronavirus pandemic on obsessive-compulsive-disorder symptoms. Rev Environ Health. 36:1. 1–8.
https://doi.org/10.1515/reveh-2020-0054
79. Salehi M, Amanat M, Mohammadi M, Salmanian M, Rezaei N, Saghazadeh A, Garakani A. 2021; The prevalence of post-traumatic stress disorder related symptoms in coronavirus outbreaks: a systematic-review and meta-analysis. J Affect Disord. 282:527–538.
https://doi.org/10.1016/j.jad.2020.12.188
80. Cooke JE, Eirich R, Racine N, Madigan S. 2020; Prevalence of posttraumatic and general psychological stress during COVID-19: a rapid review and meta-analysis. Psychiatry Res. 292:113347
https://doi.org/10.1016/j.psychres.2020.113347
81. da Silva ML, Rocha RSB, Buheji M, Jahrami H, Cunha KDC. 2021; A systematic review of the prevalence of anxiety symptoms during coronavirus epidemics. J Health Psychol. 26:1. 115–125.
https://doi.org/10.1177/1359105320951620
82. Numbers K, Brodaty H. 2021; The effects of the COVID-19 pandemic on people with dementia. Nat Rev Neurol. 17:2. 69–70.
https://doi.org/10.1038/s41582-020-00450-z
83. Iodice F, Cassano V, Rossini PM. 2021; Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer’s disease populations. Neurol Sci. 42:2. 455–465.
https://doi.org/10.1007/s10072-020-04902-8
84. Javelot H, Weiner L. 2021; Panic and pandemic: narrative review of the literature on the links and risks of panic disorder as a consequence of the SARS-CoV-2 pandemic. Encephale. 47:1. 38–42.
https://doi.org/10.1016/j.encep.2020.08.001
85. Hernández-Gómez A, Andrade-González N, Lahera G, Vieta E. 2021; Recommendations for the care of patients with bipolar disorder during the COVID-19 pandemic. J Affect Disord. 279:117–121.
https://doi.org/10.1016/j.jad.2020.09.105
86. Costanza A, Di Marco S, Burroni M, Corasaniti F, Santinon P, Prelati M, Chytas V, Cedraschi C, Ambrosetti J. 2020; Meaning in life and demoralization: a mental-health reading perspective of suicidality in the time of COVID-19. Acta Biomed. 91:4. e2020163
https://doi.org/10.23750/abm.v91i4.10515
87. Conejero I, Berrouiguet S, Ducasse D, Leboyer M, Jardon V, Olié E, Courtet P. 2020; Suicidal behavior in light of COVID-19 outbreak: clinical challenges and treatment perspectives. Encephale. 46:3S. S66–S72.
https://doi.org/10.1016/j.encep.2020.05.001
88. Walsh O, McNicholas F. 2020; Assessment and management of anorexia nervosa during COVID-19. Ir J Psychol Med. 37:3. 187–191.
https://doi.org/10.1017/ipm.2020.60
89. Jahrami H, BaHammam AS, Bragazzi NL, Saif Z, Faris M, Vitiello MV. 2021; Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis. J Clin Sleep Med. 17:2. 299–313.
https://doi.org/10.5664/jcsm.8930
90. Datta K, Tripathi M. 2021; Sleep and Covid-19. Neurol India. 69:1. 26–31.
https://doi.org/10.4103/0028-3886.310073
91. Souza LFF, Paineiras-Domingos LL, Melo-Oliveira MES, Pessanha-Freitas J, Moreira-Marconi E, Lacerda ACR, Mendonça VA, Sá-Caputo DDC, Bernardo-Filho M. 2021; The impact of COVID-19 pandemic in the quality of sleep by Pittsburgh Sleep Quality Index: a systematic review. Cien Saude Colet. 26:4. 1457–1466.
https://doi.org/10.1590/1413-81232021264.45952020
92. Kim SW, Su KP. 2020; Using psychoneuroimmunity against COVID-19. Brain Behav Immun. 87:4–5.
https://doi.org/10.1016/j.bbi.2020.03.025
93. Puyat JH, Ahmad H, Avina-Galindo AM, Kazanjian A, Gupta A, Ellis U, Ashe MC, Vila-Rodriguez F, Halli P, Salmon A, Vigo D, Almeida A, De Bono CE. 2020; A rapid review of home-based activities that can promote mental wellness during the COVID-19 pandemic. PLoS One. 15:12. e0243125
https://doi.org/10.1371/journal.pone.0243125
94. Hou WK, Lai FT, Ben-Ezra M, Goodwin R. 2020; Regularizing daily routines for mental health during and after the COVID-19 pandemic. J Glob Health. 10:2. 020315
https://doi.org/10.7189/jogh.10.020315
95. Jakovljevic M, Jakovljevic I, Bjedov S, Mustac F. 2020; Psychiatry for better world: COVID-19 and blame games people play from public and global mental health perspective. Psychiatr Danub. 32:2. 221–228.
https://doi.org/10.24869/psyd.2020.221
96. Blanc J, Briggs AQ, Seixas AA, Reid M, Jean-Louis G, Pandi-Perumal SR. 2021; Addressing psychological resilience during the coronavirus disease 2019 pandemic: a rapid review. Curr Opin Psychiatry. 34:1. 29–35.
https://doi.org/10.1097/YCO.0000000000000665
97. Williams CYK, Townson AT, Kapur M, Ferreira AF, Nunn R, Galante J, Phillips V, Gentry S, Usher-Smith JA. 2021; Interventions to reduce social isolation and loneliness during COVID-19 physical distancing measures: a rapid systematic review. PLoS One. 16:2. e0247139
https://doi.org/10.1371/journal.pone.0247139
98. Prisco V, Prisco L, Donnarumma B. 2020; Telepsychiatry in adults and adolescents: a useful tool against CoViD-19. Recenti Prog Med. 111:7. 411–414.
https://doi.org/10.1701/3407.33923
99. Di Carlo F, Sociali A, Picutti E, Pettorruso M, Vellante F, Verrastro V, Martinotti G, di Giannantonio M. 2021; Telepsychiatry and other cutting-edge technologies in COVID-19 pandemic: bridging the distance in mental health assistance. Int J Clin Pract. 75:1. 10.1111/ijcp.13716
https://doi.org/10.1111/ijcp.13716
100. Yue JL, Yan W, Sun YK, Yuan K, Su SZ, Han Y, Ravindran AV, Kosten T, Everall I, Davey CG, Bullmore E, Kawakami N, Barbui C, Thornicroft G, Lund C, Lin X, Liu L, Shi L, Shi J, Ran MS, Bao YP, Lu L. 2020; Mental health services for infectious disease outbreaks including COVID-19: a rapid systematic review. Psychol Med. 50:15. 2498–2513.
https://doi.org/10.1017/S0033291720003888
101. Zhang M, Smith HE. 2020; Digital tools to ameliorate psychological symptoms associated with COVID-19: scoping review. J Med Internet Res. 22:8. e19706
https://doi.org/10.2196/19706
102. Simpson S, Richardson L, Pietrabissa G, Castelnuovo G, Reid C. 2021; Videotherapy and therapeutic alliance in the age of COVID-19. Clin Psychol Psychother. 28:2. 409–421.
https://doi.org/10.1002/cpp.2521
103. Monroy-Fraustro D, Maldonado-Castellanos I, Aboites-Molina M, Rodríguez S, Sueiras P, Altamirano-Bustamante NF, de Hoyos-Bermea A, Altamirano-Bustamante MM. 2021; Bibliotherapy as a non-pharmaceutical intervention to enhance mental health in response to the COVID-19 pandemic: a mixed-methods systematic review and bioethical meta-analysis. Front Public Health. 9:629872
https://doi.org/10.3389/fpubh.2021.629872
104. Ma K, Wang X, Feng S, Xia X, Zhang H, Rahaman A, Dong Z, Lu Y, Li X, Zhou X, Zhao H, Wang Y, Wang S, Baloch Z. 2020; From the perspective of traditional Chinese medicine: treatment of mental disorders in COVID-19 survivors. Biomed Pharmacother. 132:110810
https://doi.org/10.1016/j.biopha.2020.110810
105. Shahrajabian MH, Sun W, Soleymani A, Cheng Q. 2021; Traditional herbal medicines to overcome stress, anxiety and improve mental health in outbreaks of human coronaviruses. Phytother Res. 35:3. 1237–1247.
https://doi.org/10.1002/ptr.6888
106. Park JE, Kang S-H, Won S-D, Roh D, Kim W-H. 2015; Assessment instruments for disaster behavioral health. Anxiety and Mood. 11:2. 91–105.
107. Cameron RP, Gusman D. 2003; The primary care PTSD screen (PC-PTSD): development and operating characteristics. Primary care psychiatry. 9:1. 9–14.
108. Kroenke K, Spitzer RL, Williams JB. 2001; The PHQ-9: validity of a brief depression severity measure. Journal of general internal medicine. 16:9. 606–613.
https://doi.org/10.1046/j.1525-1497.2001.016009606.x
109. Arroll B, Goodyear-Smith F, Crengle S, Gunn J, Kerse N, Fishman T, Falloon H, Hatcher S. 2010; Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. The annals of family medicine. 8:4. 348–353.
https://doi.org/10.1370/afm.1139
110. Martin A, Rief W, Klaiberg A, Braehler E. 2006; Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population. General hospital psychiatry. 28:1. 71–77.
https://doi.org/10.1016/j.genhosppsych.2005.07.003
111. Park SJ, Choi HR, Choi JH, Kim KW, Hong JP. 2010; Reliability and validity of the Korean version of the Patient Health Questionnaire-9 (PHQ-9). Anxiety and mood. 6:2. 119–124.
112. Spitzer RL, Kroenke K, Williams JB, Löwe B. 2006; A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of internal medicine. 166:10. 1092–1097. 10.1001/archinte.166.10.1092
113. Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Herzog W, Herzberg PY. 2008. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Medical care. 266–274.
https://www.jstor.org/stable/40221654
114. Lee SH, Shin C, Kim H, Jeon SW, Yoon HK, Ko YH, Pae CU, Han C. 2022; Validation of the Korean version of the generalized anxiety disorder 7 self-rating scale. Asia-Pacific Psychiatry. 14:1. e12421
https://doi.org/10.1111/appy.12421
115. Kroenke K, Spitzer RL, Williams JB. 2002; The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosomatic medicine. 64:2. 258–266.
116. van Ravesteijn H, Wittkampf K, Lucassen P, van de Lisdonk E, van den Hoogen H, van Weert H, Huijser J, Schene A, van Weel C, Speckens A. 2009; Detecting somatoform disorders in primary care with the PHQ-15. The Annals of Family Medicine. 7:3. 232–238.
https://doi.org/10.1370/afm.985
117. Kocalevent RD, Hinz A, Brähler E. 2013; Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population. BMC psychiatry. 13:1. 1–8.
https://doi.org/10.1186/1471-244X-13-91
118. Han C, Pae CU, Patkar AA, Masand PS, Kim KW, Joe SH, Jung IK. 2009; Psychometric properties of the Patient Health Questionnaire–15 (PHQ–15) for measuring the somatic symptoms of psychiatric outpatients. Psychosomatics. 50:6. 580–585.
https://doi.org/10.1016/S0033-3182(09)70859-X
119. Lee S, Huh Y, Kim J. 2014; Finding optimal cut off points of the Korean version of the Patient Health Questionnaire-9 (PHQ-9) for screening depressive disorders. Mood Emot. 12:1. 32–36.
120. Kyung Hee University Korean Medicine Hospital at Gangdong. 2020; Manual for doctors of Korean medicine at COVID-19 treatment sites.
121. Pfefferbaum B, North CS. 2020; Mental health and the Covid-19 pandemic. New England Journal of Medicine. 383:6. 510–512.
https://doi.org/10.1056/NEJMp2008017
122. Kwon JH, Kim JW, Park DG, Lee MS, Min SG, Kwon HI. 2008; Development and validation of the Hwa-Byung Scale. The Korean Journal of Clinical Psychology. 27:1. 237–252.
123. Lee Y, Baek Y, Park K, Jin HJ, Lee S. 2016; Development and validation of an instrument to measure the health status of healthy but unsatisfied people: Mibyeong index (未病 index). Journal of Society of Preventive Korean Medicine. 20:3. 45–53.
124. National Institute for Health and Care Excellence (NICE). 2014. Anxiety disorders Quality standard. NICE;Available from: www.nice.org.uk/guidance/qs53
Accessed March 26 2020.
125. National Institute for Health and Care Excellence (NICE). 2018. Posttraumatic stress disorder NICE guideline. NICE;Available from: www.nice.org.uk/guidance/ng116
Accessed March 26 2020.
126. Kwak HY, Hong SG, Kim JW. 2020; Research Trends in Mind-Body Intervention in the COVID-19 Pandemic. Korean Society for Meditation. 10:2. 53–71.